Inventor · disambiguated record
Reinhard Gabathuler
Also filed as: GABATHULER REINHARD
23 granted patents·14 pending applications·161 citations·filing 1995–2022
95Inventor score
Files withBIOASIS TECHNOLOGIES INC15BIOMARIN PHARM INC4UNIV BRITISH COLUMBIA4CAVA HEALTHCARE INC3ANGIOCHEM INC2
Top patents by PatentIndex Score
37 records- 0195US7700554B2Compositions for modulating blood-brain barrier transportRAPTOR PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·44 cites·2 claims
- 0294US9364567B2Fragments of p97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2014·Granted Jun 14, 2016·25 cites·25 claims
- 0393US9850472B2P97-antibody conjugates and methods of useBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Dec 26, 2017·8 cites·14 claims
- 0492US9150846B2P97-antibody conjugates and methods of useJEFFERIES WILFRED·Filed 2012·Granted Oct 6, 2015·18 cites·17 claims
- 0591US10772939B2Fragments of P97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2018·Granted Sep 15, 2020·3 cites·15 claims
- 0691US9993530B2Fragments of P97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2016·Granted Jun 12, 2018·8 cites·11 claims
- 0791US7560431B2Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agentsRAPTOR PHARMACEUTICAL INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0886US9932565B2Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2013·Granted Apr 3, 2018·7 cites·7 claims
- 0983US8828925B2Etoposide and doxorubicin conjugates for drug deliveryDEMEULE MICHEL·Filed 2009·Granted Sep 9, 2014·6 cites·7 claims
- 1080US7977317B2Compositions and methods for modulating blood-brain barrier transportRAPTOR PHARMACEUTICAL INC·Filed 2010·Granted Jul 12, 2011·4 cites·9 claims
- 1177US8710013B2Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and useDEMEULE MICHEL·Filed 2009·Granted Apr 29, 2014·5 cites·31 claims
- 1275US11492400B2Antibodies to L-type voltage gated channels and related methodsUNIV BRITISH COLUMBIA·Filed 2020·Granted Nov 8, 2022·1 cites·1 claims
- 1374US12011421B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2021·Granted Jun 18, 2024·0 cites·5 claims
- 1470US12077582B2Antibodies to L-type voltage gated channels and related methodsUNIV BRITISH COLUMBIA·Filed 2022·Granted Sep 3, 2024·0 cites·1 claims
- 1570US10392605B2P97-IDS fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Aug 27, 2019·1 cites·20 claims
- 1669US11197832B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2020·Granted Dec 14, 2021·0 cites·5 claims
- 1769US11034943B2Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2018·Granted Jun 15, 2021·0 cites·8 claims
- 1869US2021388330A1Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1968US2020376092A1Fragments of p97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2067US10058619B2P97-polynucleotide conjugatesBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Aug 28, 2018·1 cites·13 claims
- 2166US11124781B2P97-IDS fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2019·Granted Sep 21, 2021·0 cites·12 claims
- 2264US10751296B2Curcuphenol compounds for increasing MHC-I expressionCAVA HEALTHCARE INC·Filed 2017·Granted Aug 25, 2020·0 cites·12 claims
- 2363US11643454B2P97 fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2019·Granted May 9, 2023·0 cites·3 claims
- 2461US2015147314A1Curcuphenol compounds for increasing mhc-i expressionBIOMMUNE TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 2556US2015038429A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2014·Application pending·0 cites
- 2656US2005026823A1Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissuesBIOMARIN PHARM INC·Filed 2003·Application pending·0 cites
- 2754US2022048992A1Combination therapies for delivery across the blood brain barrierBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2850US2003129186A1Compositions and methods for modulating blood-brain barrier transportBIOMARIN PHARM INC·Filed 2002·Application pending·0 cites
- 2949US5792604AMethod of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathwayUNIV BRITISH COLUMBIA·Filed 1996·Granted Aug 11, 1998·8 cites·21 claims
- 3049US2004176270A1Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugatesBIOMARIN PHARM INC·Filed 2003·Application pending·0 cites
- 3149US2016375145A1Etoposide and doxorubicin conjugates for drug deliveryANGIOCHEM INC·Filed 2016·Application pending·0 cites
- 3248US6361770B1Method of enhancing expression of MHC class I molecules bearing endogenous peptidesUNIV BRITISH COLUMBIA·Filed 1995·Granted Mar 26, 2002·6 cites·10 claims
- 3348US2006029586A1Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugatesBIOMARIN PHARM INC·Filed 2005·Application pending·0 cites
- 3445US2002119095A1Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumoursFiled 2001·Application pending·0 cites
- 3543US2019022244A1Blood-brain barrier vector compounds and conjugates thereofBIOASIS TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 3640US2016347821A1P97 fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
- 3737US2018022803A1Antibodies to l-type voltage gated channels and related methodsBIOMMUNE TECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Reinhard Gabathuler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →